Health State Questionnaires Deployed in Ulcerative Colitis Patients: The Medical, Psychological, and Economic Perspective
Damien S. E. Broekharst(Maastricht University), Tessa E H Römkens(Jeroen Bosch Ziekenhuis), Sjaak Bloem(Nyenrode Business University), Pepijn W. A. Thomas(Radboud University Nijmegen), Rachel West(Sint Franciscus Gasthuis), Jeroen M. Jansen(OLVG), Maurice G. Rüssel(Medisch Spectrum Twente)
Cited by 2
Related Papers
Endoscopic or surgical step-up approach for infected necrotising pancreatitis: a multicentre randomised trial
|The Lancet|2017|732
Immediate versus Postponed Intervention for Infected Necrotizing Pancreatitis
|New England Journal of Medicine|2021|269
Ustekinumab for Crohn’s Disease: Results of the ICC Registry, a Nationwide Prospective Observational Cohort Study
|Journal of Crohn s and Colitis|2019|183
Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn’s disease patients with prior failure to anti‐TNF treatment
|Alimentary Pharmacology & Therapeutics|2020|129